167 related articles for article (PubMed ID: 35308238)
1. Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute.
Hurst J; Rickmann A; Heider N; Hohenadl C; Reither C; Schatz A; Schnichels S; Januschowski K; Spitzer MS
Front Pharmacol; 2022; 13():817353. PubMed ID: 35308238
[No Abstract] [Full Text] [Related]
2. A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.
Barth H; Crafoord S; Andréasson S; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):697-703. PubMed ID: 26743755
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment.
Schnichels S; Schneider N; Hohenadl C; Hurst J; Schatz A; Januschowski K; Spitzer MS
PLoS One; 2017; 12(3):e0172895. PubMed ID: 28248989
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model.
Barth H; Crafoord S; Arnér K; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):769-783. PubMed ID: 30656473
[TBL] [Abstract][Full Text] [Related]
5. Experimental vitreous tamponade using polyalkylimide hydrogel.
Crafoord S; Andreasson S; Ghosh F
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1167-74. PubMed ID: 21452039
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes.
Wang P; Gao Q; Jiang Z; Lin J; Liu Y; Chen J; Zhou L; Li H; Yang Q; Wang T
Clin Exp Ophthalmol; 2012; 40(1):e67-75. PubMed ID: 21883770
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility of polyvinyl alcohol/trisodium trimetaphosphate as vitreous substitute in experimental vitrectomy model in rabbits.
de Oliveira RA; Muralha FP; Grupenmacher AT; de Araújo Morandim-Giannetti A; Bersanetti PA; Maia M; Magalhães Junior O
J Biomed Mater Res B Appl Biomater; 2022 Feb; 110(2):460-466. PubMed ID: 34328263
[TBL] [Abstract][Full Text] [Related]
8. A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve.
Gao Q; Mou S; Ge J; To CH; Hui Y; Liu A; Wang Z; Long C; Tan J
Eye (Lond); 2008 Mar; 22(3):461-8. PubMed ID: 17525767
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of viscoelastic poly(ethylene glycol) sols as vitreous substitutes in an experimental vitrectomy model in rabbits.
Pritchard CD; Crafoord S; Andréasson S; Arnér KM; O'Shea TM; Langer R; Ghosh FK
Acta Biomater; 2011 Mar; 7(3):936-43. PubMed ID: 21081184
[TBL] [Abstract][Full Text] [Related]
10. VITREORETINAL SURGERY WITH SILICONE OIL TAMPONADE IN PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT: Clinical Outcomes and Complications.
Antoun J; Azar G; Jabbour E; Kourie HR; Slim E; Schakal A; Jalkh A
Retina; 2016 Oct; 36(10):1906-12. PubMed ID: 26966864
[TBL] [Abstract][Full Text] [Related]
11. Injectable alginate-based in situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function.
Choi G; An SH; Choi JW; Rho MS; Park WC; Jeong WJ; Cha HJ
Biomaterials; 2024 Mar; 305():122459. PubMed ID: 38199216
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between vitrectomy and the morphology and function of the retina].
Terasaki H
Nippon Ganka Gakkai Zasshi; 2003 Dec; 107(12):836-64; discussion 865. PubMed ID: 14733133
[TBL] [Abstract][Full Text] [Related]
13. Effect on rabbits' intraocular structure by cross-linked hyaluronic formations as vitreous substitute.
Gong Y; Chen K; Wu Y; Guo XH; Zhang T
Int J Ophthalmol; 2020; 13(10):1531-1537. PubMed ID: 33078101
[TBL] [Abstract][Full Text] [Related]
14. Safety and performance assessment of hyaluronic acid-based vitreous substitutes in patients with phthisis bulbi.
Schulz A; Wakili P; Januschowski K; Heinz WR; Engelhard M; Menz H; Szurman P
Acta Ophthalmol; 2023 Sep; 101(6):687-695. PubMed ID: 36912796
[TBL] [Abstract][Full Text] [Related]
15. Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes.
Chen S; Tian M; Zhang L; Hu C; Liu K; Qin B; Liu S
Transl Vis Sci Technol; 2021 Sep; 10(11):8. PubMed ID: 34491287
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment.
Lin X; Ge J; Gao Q; Wang Z; Long C; He L; Liu Y; Jiang Z
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):374-81. PubMed ID: 20811065
[TBL] [Abstract][Full Text] [Related]
17. Rabbit study of an in situ forming hydrogel vitreous substitute.
Swindle-Reilly KE; Shah M; Hamilton PD; Eskin TA; Kaushal S; Ravi N
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4840-6. PubMed ID: 19324846
[TBL] [Abstract][Full Text] [Related]
18. Preliminary efficacy and safety of a silicone oil-filled foldable capsular vitreous body in the treatment of severe retinal detachment.
Lin X; Wang Z; Jiang Z; Long C; Liu Y; Wang P; Jin C; Yi C; Gao Q
Retina; 2012 Apr; 32(4):729-41. PubMed ID: 22105508
[TBL] [Abstract][Full Text] [Related]
19. Injectable self-crosslinking hydrogels based on hyaluronic acid as vitreous substitutes.
Yu S; Wang S; Xia L; Hu H; Zou M; Jiang Z; Chi J; Zhang Y; Li H; Yang C; Liu W; Han B
Int J Biol Macromol; 2022 May; 208():159-171. PubMed ID: 35301003
[TBL] [Abstract][Full Text] [Related]
20. Stable oxime-crosslinked hyaluronan-based hydrogel as a biomimetic vitreous substitute.
Baker AEG; Cui H; Ballios BG; Ing S; Yan P; Wolfer J; Wright T; Dang M; Gan NY; Cooke MJ; Ortín-Martínez A; Wallace VA; van der Kooy D; Devenyi R; Shoichet MS
Biomaterials; 2021 Apr; 271():120750. PubMed ID: 33725584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
